Global immunization efforts are currently under a growing threat as misinformation, humanitarian crises, and funding cuts jeopardize decades of progress. During World Immunization Week, observed from April 24–30, the World Health Organization (WHO), UNICEF, and Gavi issued a joint warning that these factors are leaving millions of children, adolescents, and adults at risk. Outbreaks of vaccine-preventable diseases—including measles, meningitis, and yellow fever—are rising globally. Furthermore, diseases like diphtheria, which had long been held at bay or virtually disappeared in many countries, are now at risk of re-emerging.
In response to these trends, these agencies are calling for urgent and sustained political attention and investment to strengthen immunization programs. This support is deemed essential to protect the significant progress achieved in reducing child mortality over the past 50 years. As WHO Director-General Dr. Tedros Adhanom Ghebreyesus noted, Vaccines have saved more than 150 million lives over the past five decades.
The clinical reality of these threats was highlighted at the Association for Molecular Pathology (AMP) Annual Meeting on Thursday, November 13. Benjamin Pinsky, MD, PhD, a professor of pathology and medicine at Stanford University School of Medicine, delivered a session titled Emerging Public Health Threats: Re-Emerging Vaccine-Preventable Infectious Diseases. Pinsky traced how pandemic-related disruptions, declining vaccine confidence, and reduced global immunization coverage have created fertile ground for outbreaks long thought to be under control. Pinsky’s presentation emphasized the re-emergence of vaccine-preventable infectious diseases, most notably measles, in the wake of the COVID-19 pandemic.
Measles, a highly contagious disease caused by a virus belonging to the genus Morbillivirus, spreads rapidly through respiratory droplets. Symptoms include a characteristic red rash, high fever, cough, inflamed eyes, and a runny nose. Infants and young children under five years of age are the most susceptible to this infection, particularly those who are unvaccinated or immunocompromised.
Robert F. Kennedy Jr.’s Rhetoric Triggers Vaccine Industry Concerns
The consequences of failing to maintain high immunization rates extend beyond immediate infection. History has shown how vaccine-preventable diseases can roar back when trust in shots or access to them falters. Concerns have been raised regarding the rhetoric of political figures, such as Health Secretary Robert F. Kennedy Jr., whose public questioning of vaccine safety has prompted fears that manufacturers might pull back from the U.S. market.
For more on this story, see Global Health Crisis: OECD Warns of 60% Funding Collapse-Risking 39M More in Poverty & Reversing Decades of Progress on HIV, TB & Malaria.
The danger of declining coverage is not limited to the United States. As the U.S. shifts its international aid priorities, deadly and disabling diseases—such as diphtheria, rubella, and polio—continue to harm populations overseas. These diseases can easily cross borders and reach the U.S. The human impact of these gaps is visible in clinical settings; for instance, Dr. Adam Ratner treated a gravely ill 3-month-old infant in a New York City intensive care unit in 2022. The infant had spiked a fever, become lethargic, suffered seizures, and struggled to breathe.
Historical context remains vital to understanding current challenges. There have been past instances where support for immunization was abruptly halted due to unfounded accusations regarding safety. In one notable case, an accusation was made that a whole-cell pertussis vaccine was killing more children than it was helping. It was later determined that the scientific data put forth to support that hypothesis was not real, and even those who originally proposed it could not replicate the findings. Similar controversies have surrounded thimerosal, a mercury-containing preservative. Scientific consensus clarifies that the preservative uses ethyl, not methyl, mercury, does not build up in the body, and does not cause the health issues often attributed to it in public discourse.
Academic Research and Public Health Guidance
The academic community continues to prioritize these issues through specialized publications. For example, the journal Vacunas, the official journal of the Asociación Española de Vacunología, publishes research on vaccine-preventable diseases in humans and zoonotic potential in animals. The journal emphasizes aspects of planning, evaluation, epidemiology, and the development of vaccination programs.
Readers seeking to understand the risks associated with these diseases or the status of local immunization programs should consult qualified medical professionals or official public health agencies. Conclusions regarding personal health or local outbreaks should be based on clinical guidance rather than general information.
Find more reporting in our Health section.
Related reading